Mobocertinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mobocertinib
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Mobocertinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 NDC API, 1 Listed Suppliers

1 API Suppliers
1 NDC API
1 Listed Suppliers

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Annual Reports

1 US Medicaid Prescriptions
2 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

2 US Patents, 2 US Exclusivities

2 US Patents
2 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2TAKEDA PHARMS USA

filter Patent Number Reset all filters

2 All

01 19796712

02 110227342

filter API Patent Reset all filters

2 All

01 2Y

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22035-05-13

Product Main Page

01

TAKEDA PHARMS USA

MOBOCERTINIB SUCCINATE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-13

MOBOCERTINIB SUCCINATE

US Patent Number : 10227342

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215310

Patent Use Code : U-3220

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-05-13

Portfolio PDF

Product Web Link

Digital Content

02

TAKEDA PHARMS USA

MOBOCERTINIB SUCCINATE

2024 ACI Convention

Not Confirmed

TAKEDA PHARMS USA

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-13

MOBOCERTINIB SUCCINATE

US Patent Number : 9796712

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215310

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-05-13

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?